NCT06580236View on ClinicalTrials.gov

Study of the Drug B11-FC (Botulism Treatment)

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

March 30, 2025

Study Completion Date

March 30, 2025

Conditions
Botulism
Interventions
DRUG

B11-FC

Infusion

DRUG

Botulinum neurotoxin type A

Infusion

OTHER

Placebo

Infusion

All Listed Sponsors
lead

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

OTHER

NCT06580236 - Study of the Drug B11-FC (Botulism Treatment) | Biotech Hunter | Biotech Hunter